©2024 Stanford Medicine
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
Not Recruiting
Trial ID: NCT00898079
Purpose
This study is collecting and storing malignant, borderline malignant neoplasms, and related
biological samples from young patients with cancer. Collecting and storing samples of tumor
tissue, blood, and bone marrow from patients with cancer to study in the laboratory may help
the study of cancer in the future.
Official Title
A Children's Oncology Group Protocol for Collecting and Banking Pediatric Research Specimens Including Rare Pediatric Tumors
Stanford Investigator(s)
Eligibility
Inclusion Criteria:
- Meets any of the following criteria:
- Diagnosed with primary neoplasm
- Developed a second malignant neoplasm
- Any diagnoses having an ICD-O Morphology Code ending in 1, 2, or 3 as listed in
the International Classification of Disease for Oncology, Third Edition
- Must have biological specimens including solid tumors and leukemias available
- Solid tumors meeting the following criteria:
- Snap frozen primary tumor OR OCT embedded primary tumor OR formalin fixed
(block or tissue in formalin) primary tumor AND at least 10 unstained
paraffin slides for NIH Mandated QC (tumors that have undergone central
pathology review are allowed)
- Slides for pathology review (instead of slides for QC) are required for
patients with rare tumors
- Pleural fluid or cytologic specimens meeting the following criteria:
- At least 1 mL of fluid and at least 2 unstained cytospin slides (or 2
unstained smears)
- Slides for pathology review (instead of slides for QC) are required for
patients with rare tumors
- ALL/AML
- 3-6 mL of bone marrow aspirate and 10 mL of whole blood
- Not eligible for disease-specific biology or banking protocol
Intervention(s):
other: cytology specimen collection procedure
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
CCTO
650-498-7061